Epidemiology and outcomes of serious influenza-related infections in the cancer population

Cancer

Volumn 104, Issue 3, 2005, Pages 618-628

  Cooksley, Catherine D ^a   Avritscher, Elenir B C ^a   Bekele, Benjamin N ^a   Rolston, Kenneth V ^a   Geraci, Jane M ^a   Elting, Linda S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Cost; Epidemiology; Influenza; Inpatient discharge data; Outcomes

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BRONCHOPNEUMONIA; CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CODING; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH CARE COST; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFECTION RATE; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; SEASONAL VARIATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; LENGTH OF STAY; MIDDLE AGED; NEOPLASMS; ORTHOMYXOVIRIDAE; RISK FACTORS; UNITED STATES; VACCINATION;

EID: 22544461611     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21203     Document Type: Article

References (37)

1. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3-27.
2. National Cancer Institute. Estimate U.S. cancer prevalence counts. Who are our cancer survivors in the US? Cancer Control and Population Sciences: Research Findings. Bethesda: U.S. Department of Health and Human Services, 2003. Available from URL: http://dccps.nci.nih.gov/ocs/ prevalence/index.html [accessed February 16, 2005].
3. American Cancer Society. Cancer facts and figures 2004. Atlanta: American Cancer Society, 2004.
4. Center for Disease Control Division of Cancer Prevention and Control. A national action plan for cancer survivorship: advancing public health strategies. Bethesda: Centers for Disease Control, 2004.
5. National Cancer Institute President's Cancer Panel. Living beyond cancer: finding a new balance. Bethesda: U.S. Department of Health and Human Services, May 2004.
6. Harper SA, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). [erratum appears in MMWR Recomm Rep. 2004 Aug 20;53:743.] MMWR Morb Mortal Wkly Rep. 2004;53(RR-6):1-40.
7. Barker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health. 1986;76:761-765.
8. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis. 2000;181:831-837.
9. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-1340.
10. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis. 2001;184:665-670.
11. Poland GA, Couch RB, Faggett WL, Nichol KL, Sisk JE. A call to action: improving influenza and pneumoccocal immunization rates among high-risk adults. Bethesda: National Coalition for Adult Immunization, October 1998. Available from URL: http://www.nfid.org/ncai/publications/round-table/ [accessed October 6, 2004].
12. Earle CC. Influenza vaccination in elderly patients with advanced colorectal cancer. J Clin Oncol. 2003;21:1161-1166.
13. Brydak LB, Guzy J, Starzyk J, Machala M, Gozdz SS. Humoral immune response after vaccination against influenza in patients with breast cancer. Support Care Cancer. 2001;9:65-68.
14. Nordoy T, Aaberge IS, Husebekk A, et al. Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae. Med Oncol. 2002;19:71-78.
15. Lo W, Whimbey E, Elting L, Couch R, Cabanillas F, Bodey G. Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis. 1993;12:778-782.
16. Ortbals DW, Liebhaber H, Presant CA, Van Amburg AL 3rd, Lee JY. Influenza immunization of adult patients with malignant diseases. Ann Intern Med. 1977;87:552-557.
17. Brydak LB, Machala M. Humoral immune response to influenza vaccination in patients from high risk groups. Drugs. 2000;60:35-53.
18. National Inpatient Sample (NIS). NIS description of data elements. Healthcare Cost and Utilization Project (HCUP) databases, Rockville: Agency for Healthcare Research and Quality, 2004. Available from URL: http://www.hcup-us. ahrq.gov/db/nation/nis/nisdde.jsp (accessed December 1, 2004].
19. Surveillance, Epidemiology, and End Results (SEER) Program. Seer*Stat Database. Incidence-SEER 9 Regs Public-Use, Nov 2003 Sub (1973-2001). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004, based on the November 2003 submission. Available from URL: http://www.seer.cancer. gov [accessed May 31, 2005].
20. HCUPnet, Healthcare Cost and Utilization Project (HCUP) Rockville, MD: Agency for Healthcare Research and Quality, 2004. Available from URL: http://www.ahrq.gov/HCUPnet/ [accessed September 16, 2004].
21. ICD-9 CM easy coder. Volume 3. Montgomery, AL: Unicor Medical, Inc., 2002.
22. Centers for Disease Control. United States surveillance data. Bethesda: Centers for Disease Control and Prevention, 1998-2002. Available from URL: http://www.cdc.gov/flu/ weekly/ussurvdata.htm [accessed October 6, 2004].
23. U. S. Department of Labor Bureau of Labor Statistics. July 2003 Medicare cost to charge reimbursement. Washington, DC: U.S. Department of Labor, 2004.
24. Centers for Medicare and HHS Medicaid Services. Medicare program; changes to the hospital inpatient prospective payment systems and rates and costs of graduate medical education: fiscal year 2002 rates; provisions of the Balanced Budget Refinement Act of 1999; and provisions of the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000. Final rules. Federal Register. 2001;66:39827-40102.
25. SPSS, Inc. Version 11.5 Chicago: SPSS Inc., 2002.
26. Houchens R, Elixhauser A. Final report on calculating na-tionwide inpatient sample (NIS) variances. HCUP Methods Series Report #2003-2. Agency for Healthcare Research and Quality, May 30, 2003 (revised March 19, 2004).
27. An A, Watts D. New SAS procedures for analysis of sample survey data Proceedings of the Twenty-Third Annual SAS Users Group International. Available from URL: http://www. ats.ucla.edu/stat/sas/library/svy_survey.pdf [accessed November 16, 2004].
28. SAS/STAT. User's guide, version 8, volume 3. Gary, NC: SAS Institute Inc., 1999.
29. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383.
30. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-1079; discussion, 1081-1090.
31. Neuzil KM, Meilen BG, Wright PF, Mitchel EF Jr., Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children [comment]. N Engl J Med. 2000;342:225-231.
32. Neuzil KM, Wright PF, Mitchel EF Jr., Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr. 2000;137:856-864.
33. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children [comment]. N Engl J Med. 2000; 342:232-239.
34. Centers for Disease Control, Prevention. Update: influenza-associated deaths reported among children aged <18 years - United States, 2003-04 influenza season. MMWR Morb Mortal Wkly Rep. 2004;52:1286-1288.
35. Anaissie EJ, Mahfouz TH, Asian T, et al. The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management. Blood. 2004;103:1611-1617.
36. Simonsen L, Reichert TA, Viboud C, Blackwekder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med. 2005;165:265-272.
37. Glezen WP. The changing epidemiology of respiratory syncytial virus and influenza: impetus for new control measures. Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S202-206.